GlassScriptPhysician profile
Laura Riggins
NPI 1780695163
$2,346.00
in general payments reported to CMS, 2019-2025
20 companies · $1,283 in 2025
The $1,283 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $163 · 2022: $232 · 2023: $180 · 2024: $488 · 2025: $1,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,951.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $447.30 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $344.69 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $243.76 | 2024-2025 | Otezla, Repatha, Otezla |
| Pfizer INC. | $198.31 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $196.97 | 2022-2025 | Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $151.75 | 2022-2025 | Trelegy Ellipta, Shingrix |
| Cardiovascular Systems INC. | $147.77 | 2021 | |
| Merck Sharp & Dohme LLC | $94.13 | 2022-2025 | Gardasil 9, Capvaxive, Gardasil |
| Abbott Laboratories | $88.67 | 2024-2025 | Freestyle Libre 3 |
| Cranial Technologies, INC | $74.80 | 2024-2025 | Doc Band |
| E.R. Squibb & Sons, L.L.C. | $71.08 | 2022-2025 | Eliquis |
| Astellas Pharma US INC | $63.99 | 2023-2025 | Veozah |
| Abbvie INC. | $55.29 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.35 | 2022-2025 | Jardiance |
| Dexcom, INC. | $33.56 | 2024 | Dexcom G6 Transmitter |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $33.34 | 2023-2024 | Cologuard Collection Kit |
| Braintree Laboratories, INC. | $22.29 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.33 | 2025 | |
| Shield Therapeutics INC | $12.01 | 2022 | |
| Dynavax Technologies Corporation | $3.61 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Riggins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.